Does Renal Artery Supply Indicate Treatment Success of Renal Denervation?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cardiovascular and Interventional Radiology

• Publication date

  2013-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00270-013-0652-9PMID 23771326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial

  2012cited by this paper
• ESH position paper: renal denervation - an interventional therapy of resistant hypertension.

  2012cited by this paper
• Micro‐anatomy of the renal sympathetic nervous system: A human postmortem histologic study

  2012cited by this paper
• Renal Denervation: Ultima Ratio or Standard in Treatment-Resistant Hypertension

  2012cited by this paper
• Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months

  2011cited by this paper
• Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety

  2011cited by this paper
• Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

  2010influential reference
• Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults.

  2010cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

  2009cited by this paper
• Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

  2009influential reference
• Renal sympathetic-nerve ablation for uncontrolled hypertension.

  2009cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

  2009cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

  2008cited by this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Global burden of hypertension: analysis of worldwide data.

  2005cited by this paper
• Additional renal arteries incidence and morphometry

  2001cited by this paper

• NEUROMODULATION VA CATHETER APPARATUSES HAVING EXPANDABLE BASKETS

  2017cites this paper
• Renal Denervation in the Medicare Population

  2016cites this paper
• Procedural Aspects of Renal Sympathetic Denervation

  2016cites this paper
• Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging

  2016cites this paper
• Renal Denervation: Unde Venis et Quo Vadis?

  2015cites this paper
• Eligibility for Renal Denervation: Anatomical Classification and Results in Essential Resistant Hypertension

  2015cites this paper
• Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

  2014cites this paper
• What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension.

  2014cites this paper
• Renal Artery Denervation

  2014cites this paper